ABSTRACT Background: Betalains were recently identified as natural antioxidants. However, little is known about their bioavailability from dietary sources. Objective: The objective was to evaluate the bioavailability of betalains from dietary sources. Design: The plasma kinetics and urinary excretion of betalains were studied in healthy volunteers (n 8) after a single ingestion of 500 g cactus pear fruit pulp, which provided 28 and 16 mg indicaxanthin and betanin, respectively. The incorporation of betalains inLDLand the resistance of the particles to ex vivo–induced oxidation was also researched. Results: Betanin and indicaxanthin reached their maximum plasma concentrations 3 h after the fruit meal and declined according to first-order kinetics. The half-life of betanin (0.94 0.07 h) was shorter than that of indicaxanthin (2.36 0.17 h). Both compounds had disappeared from plasma by 12 h after intake. The urinary excretion of indicaxanthin and betanin over 12 h represented 76 3.0% and 3.7 0.2%, respectively, of the ingested compounds. LDL isolated 3 and 5 h after the fruit meal incorporated betalains at concentrations of 100.5 11and50 7.2pmol/mgLDLprotein, respectively. In addition, the particles appeared more resistant to ex vivo–induced oxidative injury than did the samples isolated before fruit ingestion (P 0.05)—the higher the amount of betalains incorporated, the higher the resistance. The concentrations of vitamin E and -carotene in LDL did not change significantly after fruit ingestion. Conclusion: Our results show that cactus pear fruit is a source of bioavailable betalains and suggest that indicaxanthin and betanin may be involved in the observed protection of LDL against ex vivo– induced oxidative modifications.

TESORIERE, L., ALLEGRA, M., BUTERA, D., LIVREA, M.A. (2004). Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans. THE AMERICAN JOURNAL OF CLINICAL NUTRITION, 80, 941-945.

Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans

TESORIERE, Luisa;ALLEGRA, Mario;BUTERA, Daniela;LIVREA, Maria Antonia
2004-01-01

Abstract

ABSTRACT Background: Betalains were recently identified as natural antioxidants. However, little is known about their bioavailability from dietary sources. Objective: The objective was to evaluate the bioavailability of betalains from dietary sources. Design: The plasma kinetics and urinary excretion of betalains were studied in healthy volunteers (n 8) after a single ingestion of 500 g cactus pear fruit pulp, which provided 28 and 16 mg indicaxanthin and betanin, respectively. The incorporation of betalains inLDLand the resistance of the particles to ex vivo–induced oxidation was also researched. Results: Betanin and indicaxanthin reached their maximum plasma concentrations 3 h after the fruit meal and declined according to first-order kinetics. The half-life of betanin (0.94 0.07 h) was shorter than that of indicaxanthin (2.36 0.17 h). Both compounds had disappeared from plasma by 12 h after intake. The urinary excretion of indicaxanthin and betanin over 12 h represented 76 3.0% and 3.7 0.2%, respectively, of the ingested compounds. LDL isolated 3 and 5 h after the fruit meal incorporated betalains at concentrations of 100.5 11and50 7.2pmol/mgLDLprotein, respectively. In addition, the particles appeared more resistant to ex vivo–induced oxidative injury than did the samples isolated before fruit ingestion (P 0.05)—the higher the amount of betalains incorporated, the higher the resistance. The concentrations of vitamin E and -carotene in LDL did not change significantly after fruit ingestion. Conclusion: Our results show that cactus pear fruit is a source of bioavailable betalains and suggest that indicaxanthin and betanin may be involved in the observed protection of LDL against ex vivo– induced oxidative modifications.
2004
TESORIERE, L., ALLEGRA, M., BUTERA, D., LIVREA, M.A. (2004). Absorption, excretion, and distribution of dietary antioxidant betalains in LDLs: potential health effects of betalains in humans. THE AMERICAN JOURNAL OF CLINICAL NUTRITION, 80, 941-945.
File in questo prodotto:
File Dimensione Formato  
Bioavailability.pdf

accesso aperto

Dimensione 55.87 kB
Formato Adobe PDF
55.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/33347
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 252
  • ???jsp.display-item.citation.isi??? 213
social impact